
Hořovice Hospital is a leading healthcare provider in the Czech Republic, delivering comprehensive medical services across multiple specialties. The hospital combines advanced medical technology with a highly qualified team to ensure exceptional care. Its patient-centered approach emphasizes comfort, accessibility, and personalized treatment plans, catering to both local and international patients.
Key Services at Hořovice Hospital:
Hořovice Hospital is recognized for its dedication to quality healthcare, blending innovative practices with compassionate care in a modern environment.

St. Zdislava Hospital, located in the peaceful Bohemian Highlands Hospital of the Czech Republic, has become a leader in medical care since its opening in 2007. Known as a premier Robotic surgery center in the Czech Republic, the hospital specializes in a variety of procedures, including Prostate surgery in the Czech Republic, Bariatric surgery in the Czech Republic, and kidney and bladder surgeries. St. Zdislava is committed to integrating the latest research and technologies, such as Da Vinci robotic surgery in the Czech Republic, into its treatments.
Key Highlights of St. Zdislava Hospital:
St. Zdislava Hospital remains a top destination for those seeking reliable, effective medical care in Europe, particularly in robotic surgeries and advanced medical treatments. Its reputation as one of the best hospitals for robotic surgery in Europe is supported by its commitment to high-quality patient care, modern medical infrastructure, and comprehensive healthcare services, including Orthopedic surgery in the Czech Republic, Joint replacement surgery in the Czech Republic, and more. With its focus on patient well-being and satisfaction, St. Zdislava Hospital is a key player in Czech Republic medical tourism.

MultiScan Prague, founded as a premier diagnostic and oncology center, is dedicated to providing comprehensive cancer care by integrating advanced imaging technologies with personalized treatment plans. The center focuses on early detection, precise diagnostics, and innovative therapies, ensuring the highest standards of patient care for both local and international patients.
Key Services at Oncological Center MultiScan Prague
Oncological Center MultiScan Prague is a pioneer in cancer care, combining cutting-edge technology, innovative treatments, and compassionate patient care, making it a top destination for specialized oncology services in Europe.

Motol University Hospital, located in Prague, Czech Republic, is one of the leading medical institutions in the country, well-known for its high-quality healthcare services not only in the Czech Republic but also across Eastern Europe. Since its founding in 1971, the hospital has maintained a strong focus on patient care, research, and innovative treatment methods. Accredited with the prestigious SAK certificate, Motol University Hospital operates under the Czech Ministry of Health’s supervision and stands as the largest medical facility in the country.
Key Highlights & Features of Motol University Hospital
Motol University Hospital is the largest medical facility in the Czech Republic, renowned for its high-quality healthcare services in both pediatric and adult care. The hospital provides advanced diagnostic tools like PET-MRI and robotic-assisted surgery, ensuring precise treatments. With over 2,000 beds and a team of more than 5,000 professionals, Motol excels in specialties such as oncology, neurosurgery, orthopedics, and reproductive medicine. Accredited by SAK, the hospital is committed to continuous research and offers affordable medical services with prices approximately 50% lower than hospitals in Austria and Germany.

Na Homolce Hospital, located in Prague, is one of the most advanced medical centers in the Czech Republic. Founded in 1971, it has grown into a global leader in healthcare services, specializing in cardiovascular treatments, neurosurgery, and neurology. The hospital excels in providing top-tier patient care through a combination of skilled specialists and advanced technology. With over 1700 employees and 357 beds, Na Homolce treats thousands of patients every year, performing around 16,000 operations annually.
Key Highlights of Na Homolce Hospital
Expert Medical Specialties
High Success Rates & Comprehensive Care
Advanced Medical Technologies
Patient-Centered Care & Comfort
Accreditations & Recognitions
Patient Satisfaction
Na Homolce Hospital in Prague is a globally recognized institution, committed to providing the highest standard of care through advanced medical technologies, exceptional specialists, and patient-centered services. Whether treating cardiovascular issues, neurological conditions or performing surgeries, the hospital is known for its comprehensive care and high success rates. Accredited by major health organizations, Na Homolce offers modern accommodations, clear patient communication, and a commitment to overall patient satisfaction, ensuring the best possible healthcare outcomes.



The Czech Republic is recognized for delivering hematology-oncology care within a nationally regulated European healthcare system that emphasizes clinical governance, patient safety, and evidence-based practice. Cancer and blood disorder services operate under clear legal frameworks governing hospital licensing, specialist certification, and institutional accountability. In recent years, hematology-oncology services in the country have continued to modernize through the integration of molecular diagnostics, advanced imaging, precision laboratory medicine, and multidisciplinary tumor board models that reflect current international standards rather than legacy approaches.
Hematologists and oncologists in the Czech Republic complete structured training pathways that begin with a university medical degree, followed by nationally regulated residency programs and subspecialty certification in hematology, medical oncology, or related disciplines. Professional licensing and scope of practice are overseen by national medical authorities, with mandatory participation in continuing medical education to maintain clinical competence. These standards align with internationally recognized principles referenced by organizations such as the World Health Organization, supporting consistency, safety, and ethical delivery of cancer and blood disorder care.
Hospital infrastructure supporting hematology-oncology care is largely concentrated in tertiary-care and university-affiliated medical centers. These institutions typically include specialized oncology wards, hematology laboratories, infusion units, radiotherapy facilities, and intensive care support where needed. Academic affiliations encourage multidisciplinary collaboration among hematologists, oncologists, pathologists, radiologists, surgeons, and supportive care teams, reinforcing structured decision-making and institutional oversight within regulated patient safety frameworks.
For international patients, practical considerations form an important part of treatment planning. Patients typically begin exploring options by reviewing hospital credentials, specialist profiles, and publicly available information on cancer services. In practice, hospitals often request comprehensive medical records such as pathology reports, biopsy results, imaging studies, laboratory data, and prior treatment summaries for preliminary review. Communication with international patient departments commonly takes place via secure email or online platforms, where patients and families often ask about consultation timelines, documentation requirements, visa-related medical letters, and expected duration of treatment or monitoring. Depending on the therapy involved, postoperative or post-treatment stays of 7–14 days or longer may be planned to allow for observation and early follow-up. Language support is often available through English-speaking staff or professional interpreters, and careful coordination of follow-up care after returning home is typically emphasized as part of responsible oncology care.
Across the Czech Republic, hematology-oncology services are delivered within nationally regulated systems that prioritize patient safety, clinical governance, and transparent documentation. Oversight by the Ministry of Health of the Czech Republic provides an additional layer of reassurance for patients seeking clarity and structured care when considering treatment abroad.
Hematology-oncology care in the Czech Republic reflects ongoing advancements in diagnostic and therapeutic technologies. Hospitals commonly use digital pathology, molecular and cytogenetic testing, high-resolution CT and PET imaging, and advanced laboratory platforms to support accurate diagnosis and disease classification. These tools are integrated into regulated clinical workflows designed to improve diagnostic precision while adhering to imaging and laboratory safety standards.
Compliance with international clinical and patient-safety standards is central to cancer and blood disorder care. Institutions follow strict protocols for infection control, particularly in chemotherapy units, bone marrow transplant environments, and inpatient oncology wards. Anesthesia and procedural safety are governed by standardized guidelines for invasive diagnostics or supportive procedures. Post-treatment monitoring typically involves structured laboratory follow-up, imaging surveillance, and documented clinical assessments to support continuity of care.
Continuous professional development is a core expectation for hematology-oncology specialists. Clinicians in the Czech Republic commonly participate in international conferences, professional societies, and Continuing Medical Education (CME) programs. Treatment plans are individualized based on comprehensive clinical evaluation, and informed consent is required before initiating any therapy. Final clinical decisions depend exclusively on professional assessment by licensed specialists working within accredited institutions, contributing to the country’s recognition for regulatory oversight, innovation, and patient safety in oncology care.
Chemotherapy and Systemic Therapy
Chemotherapy and systemic therapies are used to manage a wide range of hematological and solid malignancies. In the Czech Republic, planning typically involves detailed pathology review, imaging, and laboratory assessment. Treatment is delivered in regulated infusion units under strict safety and infection control protocols, with ongoing monitoring of blood counts and organ function as part of clinical oversight.
Immunotherapy
Immunotherapy involves treatments designed to support the body’s immune response against cancer cells. Diagnostic planning commonly includes molecular and biomarker testing to guide clinical evaluation. Therapies are administered in specialized oncology units with structured monitoring protocols to manage safety and treatment-related considerations under institutional governance frameworks.
Bone Marrow and Stem Cell Transplantation
Bone marrow and stem cell transplantation are complex procedures used for selected hematological conditions. Planning involves extensive diagnostic evaluation, donor matching, and multidisciplinary review. Transplants are performed in specialized units with controlled environments, strict infection prevention measures, and intensive post-procedure monitoring to support hematologic recovery.
Targeted Therapy
Targeted therapy uses agents designed to interact with specific molecular pathways involved in disease processes. Czech centers rely on advanced diagnostic testing, including genetic and molecular analysis, to inform treatment planning. Safety protocols emphasize accurate dosing, laboratory monitoring, and documentation within regulated oncology care pathways.
Radiotherapy
Radiotherapy is used as part of cancer management for various tumor types. Treatment planning involves advanced imaging and computerized dose calculation to support precision. Procedures are delivered in accredited radiotherapy centers following radiation safety standards, with clinical oversight ensuring adherence to established protocols.
Supportive Hematology Care
Supportive hematology care addresses complications related to blood disorders or cancer treatment, such as anemia or coagulation abnormalities. Diagnostic planning includes laboratory analysis and clinical assessment. Care is delivered within regulated hospital settings, focusing on functional blood stability and patient safety through structured monitoring.
Motol University Hospital
Accreditations:
National oversight by the Ministry of Health of the Czech Republic
University-affiliated teaching hospital
Specializations:
Motol University Hospital provides comprehensive hematology-oncology services within a tertiary-care academic environment, including pediatric and adult oncology, hematological malignancies, and multidisciplinary cancer care supported by advanced diagnostics and research activity.
General University Hospital in Prague
Accreditations:
National regulatory oversight
Affiliated with Charles University
Specializations:
This institution offers a broad range of oncology and hematology services, integrating systemic therapy, diagnostics, and supportive care within an academic and research-based framework.
Na Homolce Hospital
Accreditations:
Joint Commission International
Ministry of Health oversight
Specializations:
Na Homolce Hospital delivers specialized oncology services supported by advanced imaging, infusion facilities, and structured clinical governance within an internationally accredited environment.
University Hospital Brno
Accreditations:
National regulatory oversight
University affiliation
Specializations:
University Hospital Brno provides comprehensive hematology-oncology care, including systemic therapies and diagnostic services, supported by multidisciplinary collaboration and academic clinical programs.
St. Anne’s University Hospital Brno
Accreditations:
Ministry of Health oversight
Academic affiliation
Specializations:
This hospital integrates oncology and hematology services within a research-oriented academic setting, emphasizing evidence-based practice, diagnostic accuracy, and coordinated patient management.
University Hospital Hradec Králové
Accreditations:
National healthcare regulation
University affiliation
Specializations:
The hospital offers advanced hematology-oncology diagnostics and treatment within a tertiary-care environment, supported by specialized laboratories, imaging, and clinical training programs.
IKEM – Institute for Clinical and Experimental Medicine
Accreditations:
National regulatory oversight
Academic and research affiliation
Specializations:
IKEM focuses on complex medical conditions, including hematological and oncological disorders, supported by research, multidisciplinary teams, and national clinical governance structures.
| Procedure | Estimated Cost |
| Chemotherapy (per cycle) | $1,500–$4,000 |
| Immunotherapy (per cycle) | $4,000–$10,000 |
| Bone Marrow Transplantation | $40,000–$90,000 |
| Targeted Therapy (per month) | $3,000–$8,000 |
| Radiotherapy (course) | $5,000–$12,000 |
| Diagnostic Oncology Workup | $2,000–$5,000 |
Note: The prices listed above are approximate, non-binding estimates provided for general informational purposes only. Actual treatment costs may vary based on individual clinical requirements, diagnostic findings, treatment complexity, materials or technology used, physician expertise, facility type, and duration of care. Final pricing is determined only after a professional evaluation by a licensed specialist or accredited medical institution.
Choosing hematology-oncology treatment abroad can feel overwhelming, particularly when patients and families are navigating complex diagnoses. In the Czech Republic, many find reassurance in a healthcare system built on national regulation, institutional accountability, and evidence-based medicine. Hospitals and specialists operate within clearly defined legal frameworks governing licensing, clinical audits, and patient safety systems.
Specialist training standards align with European medical education requirements, emphasizing structured residency programs, subspecialty certification, and ongoing professional development. Oncology centers invest in modern medical technology, including molecular diagnostics, advanced imaging, and precision treatment planning systems. Transparency in documentation, informed consent processes, and multidisciplinary clinical review helps patients better understand care pathways and responsibilities.
Government oversight plays a central role in protecting international patients through the regulation of hospital accreditation, professional licensing, and safety standards. At the same time, certain limitations apply. Eligibility for specific therapies depends on professional evaluation, and many oncology treatments require extended stays for monitoring or repeated visits. Practical considerations such as continuity of care after returning home, coordination with local physicians, and administrative timelines are important factors that commonly influence treatment planning.
Best Clinic Abroad is a medical travel facilitator that supports patients seeking hematology-oncology care in the Czech Republic by helping them navigate non-clinical coordination processes. It is not a medical provider and does not offer diagnoses, treatment recommendations, or influence clinical decisions made by licensed specialists or accredited hospitals. Its role is limited to informational and administrative support.
➤ Hospital coordination – Support communication and coordination with accredited hospitals
➤ Appointment support – Assist with scheduling and organizing consultations
➤ Communication assistance – Help patients understand next steps without replacing medical advice
➤ Logistical guidance – Offer non-clinical support related to travel planning
Patients commonly ask about required medical records, how international patient departments communicate, and what documentation may be needed for consultations or travel; Best Clinic Abroad helps clarify these administrative steps while reinforcing that all medical decisions are made exclusively by licensed physicians. Readers may choose to connect with Best Clinic Abroad to better understand coordination pathways and available next steps.
Is hematology-oncology treatment safe in the Czech Republic for international patients?
It is natural to seek reassurance when considering cancer or blood disorder care abroad. In the Czech Republic, hematology-oncology services are delivered within a nationally regulated healthcare system overseen by the Ministry of Health, with licensed hospitals and specialists following established patient safety and clinical governance standards.
Do Czech hospitals provide visa assistance for oncology treatment?
Hospitals do not issue visas, but international patient departments commonly provide medical invitation letters or appointment confirmations. You can typically use these documents when applying for a visa through the appropriate embassy or consular authority, depending on your nationality.
Can I arrange an online hematology-oncology consultation before traveling?
Yes, online consultations are often used as an initial step. Through Best Clinic Abroad, online consultation coordination is commonly arranged with accredited hospitals, allowing you to share pathology reports and medical records for preliminary review. These consultations are informational and do not replace in-person evaluation or clinical decision-making.
Will English-speaking doctors or translators be available during my treatment?
Many hospitals that treat international patients have English-speaking medical staff, and professional medical interpreters are often available when needed. This supports clear communication during consultations, consent discussions, and care planning.
Disclaimer: This content is provided for informational purposes only and does not constitute medical advice. It reflects non-clinical observation of healthcare coordination processes and institutional practices in Czech Republic and does not represent direct medical practice. Diagnosis and treatment decisions should always be made in consultation with a licensed medical specialist based on individual clinical evaluation.
Last updated: February 2026